Rigel Pharmaceuticals (RIGL) Free Cash Flow (2010 - 2026)

Rigel Pharmaceuticals' Free Cash Flow history runs 17 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• In Q1 2026, Free Cash Flow rose 405.15% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $79.3 million (up 122.93% YoY), while the FY2025 annual figure was $75.7 million, up 140.67% from the prior year.
• Free Cash Flow was $2.7 million for Q1 2026 at Rigel Pharmaceuticals, down from $22.0 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $30.5 million in Q2 2025 to a low of -$25.9 million in Q1 2022.
• Historically, Free Cash Flow has averaged $1.8 million across 5 years, with a median of -$893000.0 in 2025.
• The sharpest annual moves came in 2022 and 2025: Free Cash Flow sank 123.49% in 2022, then soared 10011.59% in 2025.
• A 5-year view of Free Cash Flow shows it stood at -$22.0 million in 2022, then soared by 71.61% to -$6.2 million in 2023, then soared by 332.0% to $14.5 million in 2024, then surged by 51.91% to $22.0 million in 2025, then tumbled by 87.61% to $2.7 million in 2026.
• The last three Free Cash Flow figures came in at $2.7 million (Q1 2026), $22.0 million (Q4 2025), and $24.0 million (Q3 2025), per Business Quant data.